These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 36426672)

  • 1. Liposomal amphotericin B-the present.
    Maertens J; Pagano L; Azoulay E; Warris A
    J Antimicrob Chemother; 2022 Nov; 77(Suppl_2):ii11-ii20. PubMed ID: 36426672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacological opportunities for the treatment of invasive mould diseases.
    Ledoux MP; Toussaint E; Denis J; Herbrecht R
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options of invasive fungal infections in adults.
    Flückiger U; Marchetti O; Bille J; Eggimann P; Zimmerli S; Imhof A; Garbino J; Ruef C; Pittet D; Täuber M; Glauser M; Calandra T;
    Swiss Med Wkly; 2006 Jul; 136(29-30):447-63. PubMed ID: 16937323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections: the challenge continues.
    Gullo A
    Drugs; 2009; 69 Suppl 1():65-73. PubMed ID: 19877737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy.
    Ellis M; Frampton C; Joseph J; Alizadeh H; Kristensen J; Hauggaard A; Shammas F
    J Med Microbiol; 2006 Oct; 55(Pt 10):1357-1365. PubMed ID: 17005784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.
    Aversa F; Busca A; Candoni A; Cesaro S; Girmenia C; Luppi M; Nosari AM; Pagano L; Romani L; Rossi G; Venditti A; Novelli A
    J Chemother; 2017 Jun; 29(3):131-143. PubMed ID: 28335692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections.
    Leenders AC; Daenen S; Jansen RL; Hop WC; Lowenberg B; Wijermans PW; Cornelissen J; Herbrecht R; van der Lelie H; Hoogsteden HC; Verbrugh HA; de Marie S
    Br J Haematol; 1998 Oct; 103(1):205-12. PubMed ID: 9792309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal Therapy: New and Evolving Therapies.
    Nivoix Y; Ledoux MP; Herbrecht R
    Semin Respir Crit Care Med; 2020 Feb; 41(1):158-174. PubMed ID: 32000291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
    Garnacho-Montero J; Jiménez Parrilla F
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():33-7. PubMed ID: 21420575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
    Coukell AJ; Brogden RN
    Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
    Cornely OA; Maertens J; Bresnik M; Ullmann AJ; Ebrahimi R; Herbrecht R
    J Antimicrob Chemother; 2010 Jan; 65(1):114-7. PubMed ID: 19887460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential of anidulafungin in hematological patients].
    Vázquez López L; Ruiz Camps I
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
    Yamashita C; Takesue Y; Matsumoto K; Ikegame K; Enoki Y; Uchino M; Miyazaki T; Izumikawa K; Takada T; Okinaka K; Ueda T; Miyazaki Y; Mayumi T
    J Infect Chemother; 2020 Jun; 26(6):596-603. PubMed ID: 32171659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.